세계의 경심방중격 액세스 시스템 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)
Transseptal Access Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1866731
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 경심방중격 액세스 시스템 시장 규모는 2024년에 9억 300만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 6.9%로 성장하여 2031년까지 13억 9,600만 달러로 확대될 것으로 예측됩니다.
본 보고서는 경심방중격 액세스 시스템에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구성 등의 관점에서 종합적인 평가를 제공합니다.
경심방중격 액세스 시스템의 세계 판매량은 2024년 450만 대에 달했으며, 평균 판매가격은 대당 200달러였습니다. 경심방중격 액세스 시스템은 심장 중재시술에 사용되는 의료기기로, 주로 심방 중격(특히 난원공)을 통해 좌심계통에 접근하는 것을 목적으로 합니다. 심방세동 절제술, 좌심실 폐쇄, 승모판막 중재술 등의 시술에 적합합니다. 경심방중격 액세스 시스템은 심방세동 절제술과 같은 복잡한 심장 시술에서 의사의 조작성을 향상시키고 좌심방에 대한 접근을 단순화하도록 설계되었습니다.
시장의 주요 시장 촉진요인은 다음과 같습니다:
1. 심혈관질환 치료에 대한 수요 급증
심방세동 및 기타 부정맥의 높은 유병률 : 전 세계적으로 심방세동 환자 수는 지속적으로 증가하고 있으며, 2025년에는 3,000만 건을 넘어설 것으로 예상됩니다. 이에 따라 좌심계 중재술(카테터 절제술, 좌심실 폐쇄술 등)에 대한 수요가 증가하고 있습니다.
최소침습수술의 보급 확대 : 좌심계 심장중재술의 주요 기술인 경심방중격천자술은 연간 20만 건 이상의 수요가 있으며, 특히 심방세동 치료에 필수적인 기술입니다.
고령화 추세 : 전 세계적으로 65세 이상 인구 비율이 증가하고 있으며, 심혈관질환 발생률도 상승하고 있어 시장을 더욱 견인하고 있습니다.
2. 기술 혁신과 제품 진화
고주파 절제 기술의 비약적 발전 : 기존의 기계식 절제술은 위치 결정의 정확성 문제와 높은 합병증 위험 등의 문제를 안고 있었습니다. 고주파 에너지 절제술(베일리스의 제품 등)은 제어된 에너지 방출을 통해 수술의 난이도와 합병증 발생률을 감소시켜 주류로 자리 잡고 있습니다.
영상 유도 기술의 발전 : 초음파(경식도/경심실) 및 전기해부학 매핑(EAM) 기술은 절제 정확도 향상, X선 의존도 감소, 수술 안전성 향상에 기여하고 있습니다. 통합 제품 설계 : 통합형 경심방중격 천자 시스(메드트로닉 제품 등)는 수술 절차를 간소화하고 수술 효율을 향상시켜 임상 현장에서 지지를 얻고 있습니다.
3. 정책적 지원과 시장 경쟁
메디케어 적용 및 상환 정책 : 많은 국가에서 심장 중재시술이 의료보험 적용을 받아 환자 부담 경감 및 기술 보급을 촉진하고 있습니다.
대규모 시장에서의 인수 및 R&D 투자 : 메드트로닉, 보스턴 사이언티픽과 같은 기업들은 인수(예 : 보스턴 사이언티픽이 17억 5,000만 달러에 베일리스(Bayliss)를 인수)를 통해 기술 개발을 가속화하고 있으며, 시장의 집중화를 촉진하고 있습니다.
신흥시장 성장 : 의료 수준 향상과 심혈관질환 발생률 증가에 힘입어 아시아태평양(특히 중국)은 2025년부터 2031년까지 연평균 9.0%의 CAGR을 기록하며 세계에서 가장 빠르게 성장하는 시장이 될 것으로 예측됩니다.
경심방중격 액세스 시스템 시장은 심혈관 치료에 대한 수요 증가, 기술 혁신 및 제품 개선, 정책적 지원 및 시장 경쟁의 복합적인 요인에 의해 주도되고 있습니다. 고주파 기술, 이미지 유도 기술, 통합 설계가 주요 촉진요인이 될 것입니다.
이 보고서는 경심방중격 액세스 시스템 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역 및 국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.
본 보고서에서는 경심방중격 액세스 시스템 시장의 규모, 추정 및 예측, 판매량(천대 단위) 및 매출액(백만 달러 단위)에 대해 조사 분석하였습니다. 2024년을 기준년으로 하여 2020년부터 2031년까지 과거 데이터와 예측 데이터를 포함합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 경심방중격 액세스 시스템에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
Medtronic PLC
St. Jude Medical
Boston Scientific
Merit Medical Systems
Baylis Medical
Biosense Webster, Inc
Terumo Corporation
Cook Medical
Biomerics
Transseptal Solutions
Pressure Product
Huanxin Medical
유형별 부문
통합형 경심방중격 디바이스
비통합형 경심방중격 디바이스
용도별 부문
소아
성인
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSM
영문 목차
영문목차
The global market for Transseptal Access Systems was estimated to be worth US$ 903 million in 2024 and is forecast to a readjusted size of US$ 1396 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Transseptal Access Systems cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Global sales of Transseptal Access Systems will reach 4.5 million units in 2024, with an average selling price of $200 per unit. ATransseptal Access Systems is a medical device used in cardiac interventional procedures, primarily used to establish left-sided cardiac access through the atrial septum (particularly the fossa ovalis). It is suitable for procedures such as atrial fibrillation ablation, left atrial appendage closure, and mitral valve intervention. The Transseptal Access Systems is designed to improve control and simplify left atrium access for physicians during complex cardiac procedures, such as atrial fibrillation ablation.
Market drivers primarily include the following:
1. Surge in demand for cardiovascular disease treatments
The high prevalence of atrial fibrillation and other arrhythmias: The number of patients with atrial fibrillation continues to rise globally, projected to exceed 30 million cases in 2025. This is driving increased demand for left-sided cardiac interventions (such as catheter ablation and left atrial appendage closure).
The increasing prevalence of minimally invasive surgery: Transseptal puncture, a key technique for left-sided cardiac intervention, has an annual demand exceeding 200,000 procedures and is particularly essential for the treatment of atrial fibrillation.
Aging trends: The global proportion of people aged 65 and above is increasing, and the incidence of cardiovascular disease is rising, further driving the market.
2. Technological innovation and product iteration
Breakthroughs in radiofrequency ablation technology: Traditional mechanical ablation suffers from issues such as inaccurate positioning and a high risk of complications. Radiofrequency energy ablation (such as Baylis's products) reduces operational difficulty and complication rates through controlled energy release, becoming the mainstream approach.
Advances in image-guided technology: Ultrasound (transesophageal/intracardiac) and electroanatomical mapping (EAM) technologies improve ablation accuracy, reduce reliance on X-rays, and contribute to improved surgical safety. Integrated Product Design: Integrated transseptal puncture sheaths (such as Medtronic's) simplify surgical procedures, improve operational efficiency, and are gaining clinical favor.
3. Policy Support and Market Competition
Medicare Coverage and Reimbursement Policies: Many countries have included cardiac interventional procedures in their medical insurance, reducing the burden on patients and promoting technology adoption.
Large-Market Acquisitions and R&D Investment: Companies like Medtronic and Boston Scientific are accelerating their technology development through acquisitions (such as Boston Scientific's $1.75 billion acquisition of Baylis), driving market concentration.
Emerging Market Growth: The Asia-Pacific region (particularly China), driven by improved medical standards and rising cardiovascular disease incidence, has become the fastest-growing market globally, with a projected CAGR of 9.0% from 2025 to 2031.
The Transseptal Access Systems market is driven by a combination of growing demand for cardiovascular treatments, technological innovation and product iteration, and policy support and market competition. Radiofrequency technology, image guidance, and integrated design will be key growth drivers.
This report aims to provide a comprehensive presentation of the global market for Transseptal Access Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transseptal Access Systems by region & country, by Type, and by Application.
The Transseptal Access Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transseptal Access Systems.
Market Segmentation
By Company
Medtronic PLC
St. Jude Medical
Boston Scientific
Merit Medical Systems
Baylis Medical
Biosense Webster, Inc
Terumo Corporation
Cook Medical
Biomerics
Transseptal Solutions
Pressure Product
Huanxin Medical
Segment by Type
Integrated Transseptal Devices
Non-integrated Transseptal Devices
Segment by Application
Children
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transseptal Access Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transseptal Access Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transseptal Access Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Transseptal Access Systems Product Introduction
1.2 Global Transseptal Access Systems Market Size Forecast
1.2.1 Global Transseptal Access Systems Sales Value (2020-2031)
1.2.2 Global Transseptal Access Systems Sales Volume (2020-2031)
1.2.3 Global Transseptal Access Systems Sales Price (2020-2031)
1.3 Transseptal Access Systems Market Trends & Drivers
1.3.1 Transseptal Access Systems Industry Trends
1.3.2 Transseptal Access Systems Market Drivers & Opportunity
1.3.3 Transseptal Access Systems Market Challenges
1.3.4 Transseptal Access Systems Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transseptal Access Systems Players Revenue Ranking (2024)
2.2 Global Transseptal Access Systems Revenue by Company (2020-2025)
2.3 Global Transseptal Access Systems Players Sales Volume Ranking (2024)
2.4 Global Transseptal Access Systems Sales Volume by Company Players (2020-2025)
2.5 Global Transseptal Access Systems Average Price by Company (2020-2025)
2.6 Key Manufacturers Transseptal Access Systems Manufacturing Base and Headquarters
2.7 Key Manufacturers Transseptal Access Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transseptal Access Systems
2.9 Transseptal Access Systems Market Competitive Analysis
2.9.1 Transseptal Access Systems Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Transseptal Access Systems Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transseptal Access Systems as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Integrated Transseptal Devices
3.1.2 Non-integrated Transseptal Devices
3.2 Global Transseptal Access Systems Sales Value by Type
3.2.1 Global Transseptal Access Systems Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Transseptal Access Systems Sales Value, by Type (2020-2031)
3.2.3 Global Transseptal Access Systems Sales Value, by Type (%) (2020-2031)
3.3 Global Transseptal Access Systems Sales Volume by Type
3.3.1 Global Transseptal Access Systems Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Transseptal Access Systems Sales Volume, by Type (2020-2031)
3.3.3 Global Transseptal Access Systems Sales Volume, by Type (%) (2020-2031)
3.4 Global Transseptal Access Systems Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Children
4.1.2 Adult
4.2 Global Transseptal Access Systems Sales Value by Application
4.2.1 Global Transseptal Access Systems Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Transseptal Access Systems Sales Value, by Application (2020-2031)
4.2.3 Global Transseptal Access Systems Sales Value, by Application (%) (2020-2031)
4.3 Global Transseptal Access Systems Sales Volume by Application
4.3.1 Global Transseptal Access Systems Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Transseptal Access Systems Sales Volume, by Application (2020-2031)
4.3.3 Global Transseptal Access Systems Sales Volume, by Application (%) (2020-2031)
4.4 Global Transseptal Access Systems Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Transseptal Access Systems Sales Value by Region
5.1.1 Global Transseptal Access Systems Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Transseptal Access Systems Sales Value by Region (2020-2025)
5.1.3 Global Transseptal Access Systems Sales Value by Region (2026-2031)
5.1.4 Global Transseptal Access Systems Sales Value by Region (%), (2020-2031)
5.2 Global Transseptal Access Systems Sales Volume by Region
5.2.1 Global Transseptal Access Systems Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Transseptal Access Systems Sales Volume by Region (2020-2025)
5.2.3 Global Transseptal Access Systems Sales Volume by Region (2026-2031)
5.2.4 Global Transseptal Access Systems Sales Volume by Region (%), (2020-2031)
5.3 Global Transseptal Access Systems Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Transseptal Access Systems Sales Value, 2020-2031
5.4.2 North America Transseptal Access Systems Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Transseptal Access Systems Sales Value, 2020-2031
5.5.2 Europe Transseptal Access Systems Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Transseptal Access Systems Sales Value, 2020-2031
5.6.2 Asia Pacific Transseptal Access Systems Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Transseptal Access Systems Sales Value, 2020-2031
5.7.2 South America Transseptal Access Systems Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transseptal Access Systems Sales Value, 2020-2031
5.8.2 Middle East & Africa Transseptal Access Systems Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transseptal Access Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Transseptal Access Systems Sales Value and Sales Volume
6.2.1 Key Countries/Regions Transseptal Access Systems Sales Value, 2020-2031
6.2.2 Key Countries/Regions Transseptal Access Systems Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Transseptal Access Systems Sales Value, 2020-2031
6.3.2 United States Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Transseptal Access Systems Sales Value, 2020-2031
6.4.2 Europe Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Transseptal Access Systems Sales Value, 2020-2031
6.5.2 China Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.5.3 China Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Transseptal Access Systems Sales Value, 2020-2031
6.6.2 Japan Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Transseptal Access Systems Sales Value, 2020-2031
6.7.2 South Korea Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Transseptal Access Systems Sales Value, 2020-2031
6.8.2 Southeast Asia Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Transseptal Access Systems Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Transseptal Access Systems Sales Value, 2020-2031
6.9.2 India Transseptal Access Systems Sales Value by Type (%), 2024 VS 2031
6.9.3 India Transseptal Access Systems Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medtronic PLC
7.1.1 Medtronic PLC Company Information
7.1.2 Medtronic PLC Introduction and Business Overview
7.1.3 Medtronic PLC Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medtronic PLC Transseptal Access Systems Product Offerings
7.1.5 Medtronic PLC Recent Development
7.2 St. Jude Medical
7.2.1 St. Jude Medical Company Information
7.2.2 St. Jude Medical Introduction and Business Overview
7.2.3 St. Jude Medical Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 St. Jude Medical Transseptal Access Systems Product Offerings
7.2.5 St. Jude Medical Recent Development
7.3 Boston Scientific
7.3.1 Boston Scientific Company Information
7.3.2 Boston Scientific Introduction and Business Overview
7.3.3 Boston Scientific Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Boston Scientific Transseptal Access Systems Product Offerings
7.3.5 Boston Scientific Recent Development
7.4 Merit Medical Systems
7.4.1 Merit Medical Systems Company Information
7.4.2 Merit Medical Systems Introduction and Business Overview
7.4.3 Merit Medical Systems Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merit Medical Systems Transseptal Access Systems Product Offerings
7.4.5 Merit Medical Systems Recent Development
7.5 Baylis Medical
7.5.1 Baylis Medical Company Information
7.5.2 Baylis Medical Introduction and Business Overview
7.5.3 Baylis Medical Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Baylis Medical Transseptal Access Systems Product Offerings
7.5.5 Baylis Medical Recent Development
7.6 Biosense Webster, Inc
7.6.1 Biosense Webster, Inc Company Information
7.6.2 Biosense Webster, Inc Introduction and Business Overview
7.6.3 Biosense Webster, Inc Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Biosense Webster, Inc Transseptal Access Systems Product Offerings
7.6.5 Biosense Webster, Inc Recent Development
7.7 Terumo Corporation
7.7.1 Terumo Corporation Company Information
7.7.2 Terumo Corporation Introduction and Business Overview
7.7.3 Terumo Corporation Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Terumo Corporation Transseptal Access Systems Product Offerings
7.7.5 Terumo Corporation Recent Development
7.8 Cook Medical
7.8.1 Cook Medical Company Information
7.8.2 Cook Medical Introduction and Business Overview
7.8.3 Cook Medical Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Cook Medical Transseptal Access Systems Product Offerings
7.8.5 Cook Medical Recent Development
7.9 Biomerics
7.9.1 Biomerics Company Information
7.9.2 Biomerics Introduction and Business Overview
7.9.3 Biomerics Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Biomerics Transseptal Access Systems Product Offerings
7.9.5 Biomerics Recent Development
7.10 Transseptal Solutions
7.10.1 Transseptal Solutions Company Information
7.10.2 Transseptal Solutions Introduction and Business Overview
7.10.3 Transseptal Solutions Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Transseptal Solutions Transseptal Access Systems Product Offerings
7.10.5 Transseptal Solutions Recent Development
7.11 Pressure Product
7.11.1 Pressure Product Company Information
7.11.2 Pressure Product Introduction and Business Overview
7.11.3 Pressure Product Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Pressure Product Transseptal Access Systems Product Offerings
7.11.5 Pressure Product Recent Development
7.12 Huanxin Medical
7.12.1 Huanxin Medical Company Information
7.12.2 Huanxin Medical Introduction and Business Overview
7.12.3 Huanxin Medical Transseptal Access Systems Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Huanxin Medical Transseptal Access Systems Product Offerings